Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles 3D Investing: 2025 Mid-Year Economic and Market Outlook Jasmine Yu William Heard’s Decision to Shutter His Long-Short Fund Pays Off Stephen Taub While Inflation Grabs Headlines, Employment Numbers Drive Market Moves Sponsored by CME Group